Highlights:
- First killed virus vaccine to include the latest North
American strain to be identified (Ohio/2003).
- Relevant types, quantities of EIV & EHV antigens with a novel
adjuvant.
- Flexible routes of administration.
- Safe for use in pregnant mares.
Uses:
For the vaccination of healthy, susceptible horses 6 months of age or
older, including pregnant mares, as an aid in the reduction of
respiratory disease due to equine herpesvirus type 1 (EHV-1) and type
4 (EHV-4) and by equine influenza type A2 virus.
Dosage & Administration:
Using aseptic technique inoculate horses IM with a 2 mL dose.
Administer a second 2 mL dose IM in 3-4 weeks using a different
injection site. Administer a third 2 mL dose in 3-4 weeks either IM or
IN. Revaccinate annually and prior to anticipated exposure either IM
or IN.
Precautions:
Store at a temperature between 35∞ - 45∞ F (2∞ - 7∞ C). Protect from
freezing. Shake well before using. Do not vaccinate within 21 days of
slaughter.
Antidote: Epinephrine. Warning:
This product has been tested under laboratory conditions and shown to
meet all Federal standards for safety and efficacy in normal, healthy,
immunocompetent animals. This level of performance may be affected by
conditions such as stress, weather, nutrition, disease, parasitism,
other treatments, individual idiosyncrasies or impaired immunological
competency. These factors should be considered by the user when
evaluating product performance or freedom from reactions. | 
